Literature DB >> 1713916

The polymerase chain reaction for the detection of HIV-1 genomic RNA in plasma from infected individuals.

M Ottmann1, P Innocenti, M Thenadey, M Micoud, F Pelloquin, J M Seigneurin.   

Abstract

HIV (human immunodeficiency virus) viraemia in serum or plasma of HIV-infected individuals was investigated by the polymerase chain reaction assay (PCR) in combination with reverse transcription to detect HIV-1 genomic RNA. Before PCR, plasma or serum was ultracentrifuged, precipitated virions were then treated with a RNase-free DNase, and a cDNA from the HIV-1 genomic RNA was synthesized. Thirty-three fresh plasma and seven sera from either HIV-1 antibody-positive individuals or patients treated with AZT were tested. Plasma from three patients were assayed 3 or 6 months apart. Twelve sera from HIV-1 antibody-negative individuals were used as negative control. PCR was performed with primers in LTR, gag and env regions: 11 of 40 samples were positive with three primer pairs, 16 with two primer pairs and 11 with only one primer pair. PCR on HIV-1 genomic cDNA was positive in 38 out of the 40 plasma or serum samples (95%), regardless of the clinical stage of the infection: HIV-1 was detected in 14 of the 15 untreated subjects and in 24 of the 25 AZT-treated patients. HIV p24 antigen was detected in the serum of 38% of subjects (15 of 40). The results suggest that this method is suitable for the detection of viral particles in plasma or serum from HIV-1-infected individuals irrespective of antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713916     DOI: 10.1016/0166-0934(91)90165-v

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

1.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction.

Authors:  S Menzo; P Bagnarelli; M Giacca; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction.

Authors:  M Holodniy; D A Katzenstein; D M Israelski; T C Merigan
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

Review 3.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Infrequent detection of HIV-1 components in tears compared to blood of HIV-1-infected persons.

Authors:  A J Mueller; V Klauss; L Gürtler; S Geier
Journal:  Infection       Date:  1992 Sep-Oct       Impact factor: 3.553

5.  Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction.

Authors:  D Matteucci; F Baldinotti; P Mazzetti; M Pistello; P Bandecchi; R Ghilarducci; A Poli; F Tozzini; M Bendinelli
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

6.  Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.

Authors:  P Bagnarelli; S Menzo; A Valenza; A Manzin; M Giacca; F Ancarani; G Scalise; P E Varaldo; M Clementi
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  Absence of HIV-1 DNA in cartilage from HIV-positive patients.

Authors:  J Bujia; C Zietz; P Randolph; E Wilmes; L Gürtler
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

8.  Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction.

Authors:  M A Winters; L B Tan; D A Katzenstein; T C Merigan
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.